SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-004066
Filing Date
2023-01-09
Accepted
2023-01-09 06:11:08
Documents
13
Period of Report
2023-01-06
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K d447598d8k.htm   iXBRL 8-K 25215
  Complete submission text file 0001193125-23-004066.txt   189999

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA pkbo-20230106.xsd EX-101.SCH 4425
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pkbo-20230106_def.xml EX-101.DEF 14231
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE pkbo-20230106_lab.xml EX-101.LAB 23970
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pkbo-20230106_pre.xml EX-101.PRE 15264
7 EXTRACTED XBRL INSTANCE DOCUMENT d447598d8k_htm.xml XML 5856
Mailing Address 3350 W BAYSHORE RD. SUITE 100 PALO ALTO CA 94303
Business Address 3350 W BAYSHORE RD. SUITE 100 PALO ALTO CA 94303 (650) 549-9103
Peak Bio, Inc. (Filer) CIK: 0001834645 (see all company filings)

IRS No.: 852448157 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39951 | Film No.: 23516430
SIC: 2836 Biological Products, (No Diagnostic Substances)